#Biopharma #Neuroscience #ClinicalTrials
www.benzinga.com
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones - Neumora Therapeutics (NASDAQ:NMRA)
Multiple clinical data readouts expected in 2026 present opportunity for substantial value creation
KOASTAL-2 and -3 on track for consolidated topline readout in the second quarter of 2026
Plans to conduct NMRA-215 clinical program in 2026 following class-leading preclinical data from diet induced obesity model
Advancing NMRA-511 following Phase 1b results demonstrating clinically meaningful effect on CMAI total score
Cash, cash equivalents and marketable securities expected to support operations into the third quarter of 2027
WATERTOWN, Mass.
#CircadianRhythms #DementiaRisk #Neuroscience
www.news-medical.net
Weaker and fragmented circadian rhythms linked to higher dementia risk
American Academy of NeurologyJan 4 2026
Circadian rhythms that are weaker and more fragmented are linked to an increased risk of dementia, according to a new study published on December 29, 2025, in Neurology®, the medical journal of the American Academy of Neurology.
#Neuroscience #BrainConnectivity #CognitiveCapacity
neurosciencenews.com
Brain Blends Fast and Slow Signals to Shape Human Thought - Neuroscience News
Summary: Researchers mapped the brain connectivity of 960 individuals to uncover how fast and slow neural processes unite to support complex behavior.
